Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial
Open Access
- 12 May 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 48 (4) , 814-825
Abstract
In treatment-resistant schizophrenia (TRS), Clozapine is only approved treatment with undesirable side-effects, warranting better alternatives. Our hypothesis is acute followed by maintenance Electroconvulsive Therapy (M-ECT) will be comparable in efficacy and safety to Clozapine in TRS. In this open-label trial, 60 TRS patients were randomized equally to M-ECT (following an acute-course) or Clozapine. Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression Schizophrenia Scale (CGI-SCH), Montreal Cognitive Assessment (MoCA), and Global assessment of functioning (GAF) were measured and compared within and between the groups at baseline, 6 weeks, 12 weeks, and 24 weeks. SPECT-CT brain was done at baseline and 24 weeks to compare the changes in regional cerebral perfusion between the groups and correlate with the changes in the outcome-measures. The PANSS-T scores changes from baseline over the observation-points were significant in both M-ECT and clozapine groups (P < .001), with comparatively better reduction with M-ECT (P < .001). Similar trends were observed in PANSS subscales, CGI-SCH and GAF in both groups, with significantly better improvement with M-ECT over the study-period. After 24 weeks, there was significantly better perfusion with M-ECT in bilateral prefrontal and temporal cortices (P < .05). With M-ECT, a positive correlation was found between changes in PANSS-P scores and left-lateral Temporal cortical perfusion (r = .465, P = .017). Acute followed by M-ECT was more effective than clozapine over 6 months in reducing the positive and negative symptoms, general psychopathology, illness-severity, and improving the global functionality in TRS [clinicaltrials.gov: NCT03807882].Keywords
Funding Information
- India Institute of Medical Sciences (IMF/01/2018)
This publication has 51 references indexed in Scilit:
- Continuation and Maintenance Electroconvulsive Therapy for Mood Disorders: Review of the LiteratureNeuropsychobiology, 2011
- Characteristic brain hypoperfusion by 99mTc-ECD single photon emission computed tomography (SPECT) in patients with the first-episode schizophreniaEuropean Psychiatry, 2010
- A Double-Blind, Randomized Study Comparing the Efficacy and Safety of Sertindole and Risperidone in Patients With Treatment-Resistant SchizophreniaThe Journal of Clinical Psychiatry, 2010
- Left temporal lobe structural and functional abnormality underlying auditory hallucinationsFrontiers in Neuroscience, 2009
- Comparative Study of Clozapine, Electroshock and the Combination of ECT with Clozapine in Treatment-Resistant Schizophrenic PatientsPakistan Journal of Biological Sciences, 2007
- Hypofrontality in schizophrenia: a meta‐analysis of functional imaging studiesActa Psychiatrica Scandinavica, 2004
- A Double-Blind Comparative Study of Clozapine and Risperidone in the Management of Severe Chronic SchizophreniaAmerican Journal of Psychiatry, 2001
- Treatment-Resistant Schizophrenia - The Role of ClozapineCurrent Medical Research and Opinion, 1997
- What is relapse in schizophrenia?International Clinical Psychopharmacology, 1995
- Single Photon Emission Computed Tomography (SPECT) Measures of Brain Function in SchizophreniaAustralian & New Zealand Journal of Psychiatry, 1994